PROXYPHARMA LLB
ActiveSummary
PROXYPHARMA LLB has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €533k and a net result of €35k. Equity remains stable across the filed fiscal years (±2% per year). Its solvency ranks better than 85% of 10407 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability75▲+1
Solvency100▲+3
Growth78=
Track record100
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €40k at 30 days acceptable
Liquidity ample (current ratio 4.14 against 3.73 in 2024; short-term debt: 23.5% and cash: 12.2% of total assets), and 24.7% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
75.3%
Return on assets
5%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-07-2026, 7 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
7 d early
2024
15 d early
2023
47 d early
2022
52 d early
2021
41 d early
2020
44 d early
2019
46 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€35k▲ 1.6%
2024 · €35k
2018: €-7k
2019: €5k▲ +175% vs 2018
2020: €-20k▼ -482% vs 2019lowest in 8 years
2021: €42k▲ +310% vs 2020
2022: €79k▲ +90.2% vs 2021highest in 8 years
2023: €71k▼ -9.8% vs 2022
2024: €35k▼ -51.4% vs 2023
2025: €35k▲ +1.6% vs 2024
2018 → 2025
Working capital
€522k▼ 4.8%
2024 · €549k
2018: €473klowest in 8 years
2019: €501k▲ +5.9% vs 2018
2020: €489k▼ -2.5% vs 2019
2021: €540k▲ +10.5% vs 2020
2022: €537k▼ -0.5% vs 2021
2023: €568k▲ +5.7% vs 2022highest in 8 years
2024: €549k▼ -3.4% vs 2023
2025: €522k▼ -4.8% vs 2024
2018 → 2025
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€522k-€551k▲ 5.6%€573k▲ 3.9%€557k▼ 2.7%€533k▼ 4.4%
2021: €522klowest in 5 years
2022: €551k▲ +5.6% vs 2021
2023: €573k▲ +3.9% vs 2022highest in 5 years
2024: €557k▼ -2.7% vs 2023
2025: €533k▼ -4.4% vs 2024
Operating result€65k-€99k▲ 53.3%€88k▼ 12.0%€44k▼ 49.8%€43k▼ 1.8%
2021: €65k
2022: €99k▲ +53.3% vs 2021highest in 5 years
2023: €88k▼ -12.0% vs 2022
2024: €44k▼ -49.8% vs 2023
2025: €43k▼ -1.8% vs 2024lowest in 5 years
Net result€42k-€79k▲ 90.2%€71k▼ 9.8%€35k▼ 51.4%€35k▲ 1.6%
2021: €42k
2022: €79k▲ +90.2% vs 2021highest in 5 years
2023: €71k▼ -9.8% vs 2022
2024: €35k▼ -51.4% vs 2023lowest in 5 years
2025: €35k▲ +1.6% vs 2024
Result per fiscal year
Operating resultNet result
The operating result has fallen three years in a row; 2025 is 2% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €708k
Fixed assets
€19k ▼ 30.1%
Current assets
€688k ▼ 8.1%
Equity and liabilities €708k
Equity
€533k ▼ 4.4%
Debt
€175k ▼ 20.3%
Debt's share of the balance-sheet total falls from 28.2% to 24.7%. Equity and debt are lower.
Key figures and ratios
EBITDA
€53k▼
2024 · €58k
Cash flow
€45k▼
2024 · €49k
Current ratio
4.14▲
2024 · 3.73
Quick ratio
3.12▲
2024 · 2.89
Debt to equity
0.33▼
2024 · 0.39
ROE
6.6%▲
2024 · 6.2%
ROA
5.0%▲
2024 · 4.5%
Interest coverage
7.21▼
2024 · 7.60
Debt ≤ 1 year
€166k▼
2024 · €201k
Debt > 1 year
€9k▼
2024 · €19k
Income taxes
€502▼
2024 · €2k
Staff costs
€160k▲
2024 · €158k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 56 lines
Balance sheet
Code20242025
Assets
Total assets20/58€777k€708k▼
Fixed assets21/28€27k€19k▼
Tangible fixed assets22/27€26k€18k▼
Plant, machinery and equipment23€4k€2k▼
Furniture and vehicles24€12k€9k▼
Other tangible fixed assets26€11k€7k▼
Financial fixed assets28€931€931=
Current assets29/58€750k€688k▼
Stocks and contracts in progress3€169k€169k▼
Stocks30/36€169k€169k▼
Amounts receivable within one year40/41€267k€305k▲
Trade receivables40€109k€117k▲
Other amounts receivable41€158k€188k▲
Current investments50/53€144k€124k▼
Cash at bank and in hand54/58€159k€86k▼
Deferred charges and accrued income490/1€9k€4k▼
Equity and liabilities
Total equity and liabilities10/49€777k€708k▼
Equity10/15€557k€533k▼
Contributions10/11€163k€163k=
Reserves13€169k€159k▼
Distributable reserves133€169k€159k▼
Profit (loss) carried forward14€226k€211k▼
Amounts payable17/49€219k€175k▼
Amounts payable after more than one year17€19k€9k▼
Financial debts170/4€19k€9k▼
Amounts payable within one year42/48€201k€166k▼
Current portion of amounts payable after more than one year42€10k€10k▲
Trade debts44€102k€68k▼
Suppliers440/4€102k€68k▼
Taxes, remuneration and social security45€38k€28k▼
Taxes450/3€15k€2k▼
Remuneration and social security454/9€24k€26k▲
Other amounts payable47/48€51k€60k▲
Accrued charges and deferred income492/3€0€30▲
Income statement
Code20242025
Remuneration, social security and pensions62€158k€160k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€14k€10k▼
Other operating charges640/8€3k€3k▲
Gross operating margin9900€220k€217k▼
Operating profit (loss)9901€44k€43k▼
Financial income75/76B€471€10▼
Recurring financial income75€471€10▼
Financial charges65/66B€8k€7k▼
Recurring financial charges65€8k€7k▼
Profit (loss) for the period before taxes9903€37k€36k▼
Income taxes67/77€2k€502▼
Profit (loss) for the period9904€35k€35k▲
Profit (loss) for the period to be appropriated9905€35k€35k▲
Appropriation of the result
Profit (loss) to be appropriated9906€276k€261k▼
Profit (loss) brought forward from the previous period14P€241k€226k▼
Transfer from equity791/2-€10k
Transfer to equity691/2€0-
To other reserves6921€0-
Profit to be distributed694/7€50k€60k▲
Return on contributions (dividend)694-€10k
Directors or managers695€50k€50k=
Social balance
Average headcount (FTE)90872.12.1=
The notes to these accounts (19 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Accounts by statement
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | €8k | €0 | - | - | - |
| Remuneration, social security and pensions62 | €79k | €103k | €88k | €158k | €160k | ▲ 1.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €23k | €12k | €13k | €14k | €10k | ▼ 29.9% |
| Other operating charges640/8 | €2k | €2k | €5k | €3k | €3k | ▲ 6.6% |
| Gross operating margin9900 | €169k | €216k | €193k | €220k | €217k | ▼ 1.3% |
| Operating profit (loss)9901 | €65k | €99k | €88k | €44k | €43k | ▼ 1.8% |
| Financial income75/76B | - | - | - | €471 | €10 | ▼ 97.9% |
| Recurring financial income75 | - | - | - | €471 | €10 | ▼ 97.9% |
| Financial charges65/66B | €7k | €7k | €8k | €8k | €7k | ▼ 3.8% |
| Recurring financial charges65 | €7k | €7k | €8k | €8k | €7k | ▼ 3.8% |
| Profit (loss) for the period before taxes9903 | €58k | €92k | €80k | €37k | €36k | ▼ 2.6% |
| Income taxes67/77 | €16k | €13k | €8k | €2k | €502 | ▼ 75.3% |
| Profit (loss) for the period9904 | €42k | €79k | €71k | €35k | €35k | ▲ 1.6% |
| Profit (loss) for the period to be appropriated9905 | €42k | €79k | €71k | €35k | €35k | ▲ 1.6% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €654k | €753k | €762k | €777k | €708k | ▼ 8.9% |
| Fixed assets21/28 | €28k | €51k | €33k | €27k | €19k | ▼ 30.1% |
| Tangible fixed assets22/27 | €28k | €50k | €32k | €26k | €18k | ▼ 31.1% |
| Plant, machinery and equipment23 | €4k | €7k | €5k | €4k | €2k | ▼ 40.7% |
| Furniture and vehicles24 | €5k | €21k | €17k | €12k | €9k | ▼ 24.7% |
| Other tangible fixed assets26 | €19k | €23k | €10k | €11k | €7k | ▼ 35.1% |
| Financial fixed assets28 | €431 | €931 | €931 | €931 | €931 | = |
| Current assets29/58 | €626k | €702k | €729k | €750k | €688k | ▼ 8.1% |
| Stocks and contracts in progress3 | €159k | €160k | €165k | €169k | €169k | ▼ 0.1% |
| Stocks30/36 | €159k | €160k | €165k | €169k | €169k | ▼ 0.1% |
| Amounts receivable within one year40/41 | €182k | €203k | €323k | €267k | €305k | ▲ 13.9% |
| Trade receivables40 | €82k | €91k | €177k | €109k | €117k | ▲ 7.2% |
| Other amounts receivable41 | €100k | €112k | €146k | €158k | €188k | ▲ 18.6% |
| Current investments50/53 | €154k | €194k | €194k | €144k | €124k | ▼ 13.9% |
| Cash at bank and in hand54/58 | €127k | €140k | €40k | €159k | €86k | ▼ 45.7% |
| Deferred charges and accrued income490/1 | €4k | €4k | €7k | €9k | €4k | ▼ 58.0% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €654k | €753k | €762k | €777k | €708k | ▼ 8.9% |
| Equity10/15 | €522k | €551k | €573k | €557k | €533k | ▼ 4.4% |
| Contributions10/11 | €163k | €163k | €163k | €163k | €163k | = |
| Reserves13 | €118k | €147k | €169k | €169k | €159k | ▼ 5.9% |
| Non-distributable reserves130/1 | €17k | €17k | €0 | - | - | - |
| Reserves not available under the articles1311 | €17k | €17k | €0 | - | - | - |
| Distributable reserves133 | €101k | €130k | €169k | €169k | €159k | ▼ 5.9% |
| Profit (loss) carried forward14 | €241k | €241k | €241k | €226k | €211k | ▼ 6.5% |
| Amounts payable17/49 | €132k | €202k | €189k | €219k | €175k | ▼ 20.3% |
| Amounts payable after more than one year17 | €46k | €37k | €28k | €19k | €9k | ▼ 53.7% |
| Financial debts170/4 | €46k | €37k | €28k | €19k | €9k | ▼ 53.7% |
| Amounts payable within one year42/48 | €86k | €164k | €161k | €201k | €166k | ▼ 17.3% |
| Current portion of amounts payable after more than one year42 | €9k | €9k | €9k | €10k | €10k | ▲ 3.8% |
| Trade debts44 | €46k | €68k | €62k | €102k | €68k | ▼ 32.8% |
| Suppliers440/4 | €46k | €68k | €62k | €102k | €68k | ▼ 32.8% |
| Taxes, remuneration and social security45 | €30k | €37k | €38k | €38k | €28k | ▼ 27.4% |
| Taxes450/3 | €19k | €21k | €26k | €15k | €2k | ▼ 86.4% |
| Remuneration and social security454/9 | €11k | €16k | €12k | €24k | €26k | ▲ 9.3% |
| Other amounts payable47/48 | €1k | €50k | €51k | €51k | €60k | ▲ 17.3% |
| Accrued charges and deferred income492/3 | €27 | €17 | €39 | €0 | €30 | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €42k | €79k | €71k | €35k | €35k | ▲ 1.6% |
| + Depreciation and write-downs630 | €23k | €12k | €13k | €14k | €10k | ▼ 29.9% |
| Operating cash flow (approximation) | €65k | €91k | €85k | €49k | €45k | ▼ 7.6% |
| Investment in fixed assets (approximation) | - | €-34k | €5k | €-9k | €-2k | ▲ 80.0% |
| Change in cash | - | €13k | €-100k | €119k | €-73k | ▼ 161% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
24-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
16-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
14-06
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
09-06
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
31-12
Financial
Highest result since 2018net €79k ▲90.2%
Operating result €99k, net result €79k, both a record.
20-06
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
31-12
Financial
Back to profitnet €42k
Net result €42k after one loss-making year.
31-12
Financial
Equity above €500kEq €522k ▲8.7%
Equity rises from €480k to €522k.
17-06
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2020
31-12
Financial
Weakest financial yearnet €-20k
Net result drops to €-20k, the lowest in the series; recovery starts the following year.
15-06
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
2019
31-12
Financial
Back to profitnet €5k
Net result €5k after one loss-making year.
Show earlier events
31-12
Financial
Equity above €500kEq €500k ▲1%
Equity rises from €495k to €500k.
26-06
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
18-06
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
10-07
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, La Bruyère · 1 establishment unit since 2008
Ground area
2,248 m²
Building footprint
544 m²
2 parcels, Wallonia. Linked by address, not a title deed.
1 establishment unit
PROXYPHARMA LLB
since 20082.171.942.737
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 92088A0287/00X000 | Wallonia | 1,315 m² | 1 · 167 m² | - |
| 92088A0135/00X000 | Wallonia | 933 m² | 1 · 377 m² | - |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteLa Bruyère2.171.942.737
Similar companies · same sector, comparable size
APOTHEEK A. STAS
BE 0440.034.164
Hoeilaart · Eq €532,918
PHARMASAMBRE
BE 0807.904.486
Sambreville · Eq €532,591
APOTHEEK DE KOUTER
BE 0888.968.673
Denderleeuw · Eq €532,985
PHARMACIE DE LA VILLE BASSE
BE 0872.063.652
Seneffe · Eq €532,133
Apotheek Anne-Sophie Mullie
BE 0833.402.125
Zwevegem · Eq €532,130
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 3,340 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded24-06-2008
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
Scores and ratios are computed by Checked and are not a credit decision.